Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_assertion type Assertion NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_head.
- NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_assertion description "[Variants at three of these loci have previously been linked with important clinical outcomes: SLC7A9 is a risk locus for chronic kidney disease, NAT2 for coronary artery disease and genotype-dependent response to drug toxicity, and SLC6A20 for iminoglycinuria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_provenance.
- NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_assertion evidence source_evidence_curated NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_provenance.
- NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_assertion SIO_000772 21572414 NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_provenance.
- NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_assertion wasDerivedFrom ctd_human-20130708 NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_provenance.
- NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_assertion wasGeneratedBy ECO_0000218 NP30049.RA7RbxgaYKau4aZPD5hec6kHfQ6Tcbm8pN12R69uLM2yo130_provenance.